Zymeworks Ownership | Who Owns Zymeworks?
Zymeworks Ownership Summary
Zymeworks is owned by 87.59% institutional investors, 0.08% insiders, and 12.33% retail investors. Compagnie lombard odier scma is the largest institutional shareholder, holding 0% of ZYME shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.21% of its assets in Zymeworks shares.
ZYME Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Zymeworks | 87.59% | 0.08% | 12.33% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Compagnie lombard odier scma | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Compagnie lombard odier scma | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Compagnie lombard odier scma | - | - | -7.00K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Compagnie lombard odier scma | - | - | -7.00K |
Sold Out
Holder | Change |
---|---|
Compagnie lombard odier scma | -7.00K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 174 | 4.82% | 66,432,090 | 0.06% | 87 | 1.15% | 76 | 8.57% | 62 | 24.00% |
Sep 30, 2024 | 166 | 1.22% | 66,390,794 | -2.64% | 87 | 1.09% | 70 | -18.60% | 50 | - |
Jun 30, 2024 | 164 | -2.96% | 68,188,360 | 0.99% | 89 | 1.14% | 86 | -9.47% | 50 | 31.58% |
Mar 31, 2024 | 169 | 8.33% | 67,521,400 | 4.24% | 88 | 1.06% | 95 | 11.76% | 38 | - |
Dec 31, 2023 | 156 | 9.86% | 64,772,600 | 3.92% | 91 | 1.15% | 85 | 19.72% | 38 | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 2.24M | 3.21% | - |
HBM Healthcare Investments AG Ord | 2.00M | 2.90% | 299.28K |
iShares Russell 2000 ETF | 1.44M | 2.07% | -12.48K |
BNP Paribas US Small Cap Classic R | 1.24M | 1.78% | 87.70K |
Vanguard Total Stock Mkt Idx Inv | 1.22M | 1.75% | -671.45K |
UBS (Lux) Digital Health Equity SB USD | 1.08M | 1.55% | - |
UBS Lux Dgtl Hlth Eq Fd seeding P acc | 1.08M | 1.55% | - |
BNP Paribas Health Cr Innovtr Cl Cap | 796.02K | 1.14% | -107.00 |
Xtrackers S&P 500 Swap ETF 1C | 774.42K | 1.11% | - |
Xtrackers S&P 500 2xLev Dly Swap ETF 1C | 632.16K | 0.91% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 17, 2025 | EcoR1 Capital, LLC | Buy | $630.82K | |
Apr 16, 2025 | EcoR1 Capital, LLC | Buy | $825.59K | |
Apr 04, 2025 | EcoR1 Capital, LLC | Buy | $2.19M | |
Apr 03, 2025 | EcoR1 Capital, LLC | Buy | $1.43M | |
Apr 01, 2025 | EcoR1 Capital, LLC | Buy | $564.65K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | 6 | - |
2025 Q1 | 20 | 5 |
2024 Q4 | 8 | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
ZYME Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools